Archives
Guanabenz Acetate: α2-Adrenergic Receptor Agonist for GPCR R
Guanabenz Acetate: α2-Adrenergic Receptor Agonist for GPCR Research
Executive Summary: Guanabenz Acetate, supplied by APExBIO (SKU B1335), is a chemically defined α2-adrenergic receptor agonist with demonstrated selectivity for α2a, α2b, and α2c subtypes, characterized by pEC50 values of 8.25, 7.01, and approximately 5, respectively (product_spec). The compound's high purity (98–99.5%), solubility profile (insoluble in water/ethanol, soluble in DMSO up to 14.56 mg/mL), and solid-state stability at -20°C facilitate reproducible GPCR signaling studies (workflow_recommendation). Guanabenz Acetate serves as a reference agent for neuroscience receptor research and modulator of adrenergic signaling, but it is not suitable for clinical or diagnostic applications (product_spec). Its mechanism of action and research applications are further underpinned by recent mechanistic studies in stress granule and innate immunity pathways (Liu et al., Molecules 2024).
Biological Rationale
Guanabenz Acetate is a synthetic compound that selectively activates α2-adrenergic receptor subtypes, which regulate central and peripheral adrenergic signaling. These G protein-coupled receptors (GPCRs) mediate diverse physiological responses, including neurotransmitter release modulation, vascular tone, and stress granule dynamics (cefazolinmolecules.com). In neuroscience research, selective α2a-adrenergic receptor agonists like guanabenz enable precise dissection of receptor subtype function in cellular models. Guanabenz Acetate's defined receptor selectivity and solubility in DMSO facilitate high-fidelity pharmacological assays, particularly in studies exploring neuroimmune crosstalk and GPCR-mediated signaling cascades.
Mechanism of Action of Guanabenz Acetate
Guanabenz Acetate binds to α2-adrenergic receptors (α2a, α2b, α2c), stabilizing their active conformations and modulating downstream G protein signaling. The compound's pEC50 for α2a is 8.25, for α2b is 7.01, and for α2c is approximately 5, demonstrating clear subtype preference (product_spec). When applied to cell systems, Guanabenz Acetate induces Gi/o-mediated inhibition of adenylyl cyclase, reducing cAMP levels and altering cellular responses relevant to neurotransmission and stress granule assembly. Studies have shown that agonism of these receptors can modulate stress granule biology, which intersects with antiviral and innate immune pathways (Liu et al., Molecules 2024). These features make Guanabenz Acetate a valuable tool for probing GPCR signaling and broader neuroimmune mechanisms in vitro.
Evidence & Benchmarks
- Guanabenz Acetate exhibits α2a-adrenergic receptor agonist activity with a pEC50 of 8.25, supporting high-affinity binding and robust functional activation (source: product_spec).
- High chemical purity (98–99.5%) is consistently validated by HPLC and NMR, ensuring batch-to-batch reproducibility for research applications (source: product_spec).
- Solubility is reported at ≥14.56 mg/mL in DMSO, with the compound remaining insoluble in water and ethanol, requiring immediate use of DMSO stock solutions (source: product_spec).
- In neuroimmune models, guanabenz modulates stress granule assembly, intersecting with GADD34-mediated pathways relevant to host antiviral defense (source: Liu et al., Molecules 2024).
- Standard storage at -20°C preserves compound integrity and activity over defined periods (source: workflow_recommendation).
This article extends prior work (cefazolinmolecules.com), which reviewed essential receptor selectivity data, by integrating new findings on stress granule and innate immune pathway modulation.
Applications, Limits & Misconceptions
Guanabenz Acetate is widely employed in neuroscience receptor research and GPCR signaling studies. Its selectivity profile allows for subtype-specific interrogation of adrenergic pathways in neurobiology, cardiovascular research, and immune signaling (2-o-methyl-gtp.com). Recent evidence links α2-adrenergic receptor modulation with stress granule dynamics, relevant for studying viral immune evasion mechanisms (Liu et al., Molecules 2024). However, Guanabenz Acetate is not recommended for use in clinical, diagnostic, or therapeutic settings, and its solubility restricts use to DMSO-based applications.
Common Pitfalls or Misconceptions
- Guanabenz Acetate is not water- or ethanol-soluble; improper solvent choice leads to assay failure (source: product_spec).
- Long-term storage of DMSO solutions is not recommended due to potential compound decomposition (source: workflow_recommendation).
- It is not suitable for direct in vivo or clinical research without further validation, as all evidence to date is preclinical (source: product_spec).
- Purity and batch consistency should always be verified; vendor certificates are critical for reproducibility (source: product_spec).
- Effects on stress granule pathways are context-dependent and may not generalize across all cell types (source: Liu et al., Molecules 2024).
Workflow Integration & Parameters
Protocol Parameters
- GPCR signaling assay | 10 µM Guanabenz Acetate in DMSO | in vitro cell models | aligns with reported EC50 for α2a activation | product_spec
- Stress granule modulation | 5–20 µM | neuronal/immune cell culture | leverages known concentration-response in stress granule studies | DOI
- Stock solution | 14.56 mg/mL in DMSO | all in vitro workflows | ensures maximal solubility and rapid compound delivery | product_spec
- Storage | -20°C, solid state | long-term stability | prevents hydrolysis and degradation | product_spec
- Workflow recommendation | prepare fresh DMSO stocks before each use | all cellular protocols | minimizes decomposition risk | workflow_recommendation
For detailed scenario-driven best practices, see the extended guide (bendamustinesmol.com), which offers troubleshooting for GPCR signaling and cell viability assays. This article updates protocol guidance by integrating new stress granule mechanistic insights.
Conclusion & Outlook
Guanabenz Acetate, as supplied by APExBIO, provides a rigorously characterized platform for selective α2-adrenergic receptor agonism in GPCR signaling and neuroscience research. Its high purity, robust solubility in DMSO, and stability under recommended storage enable reliable experimental design (product_spec). Recent research highlights cross-domain relevance to innate immune signaling and stress granule biology, suggesting broader utility in neuroimmune investigations (Liu et al., Molecules 2024). Ongoing studies will determine the full translational potential and limitations of this agent, but all current use should remain within the boundaries of approved research applications.
This article clarifies and extends the findings of previous work by providing updated, peer-reviewed evidence and protocol optimizations for advanced neuroimmune and GPCR workflows.